Phase II/III Study of YM150 A Placebo-Controlled, Double-Blind, Group Comparison Study in Patients Undergoing Elective Total Knee Replacement Surgery
Phase of Trial: Phase II/III
Latest Information Update: 01 Mar 2014
At a glance
- Drugs Darexaban (Primary) ; Enoxaparin sodium
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Registrational; Therapeutic Use
- Sponsors Astellas Pharma
- 15 Jun 2010 Actual end date (January 2010) added as reported by ClinicalTrials.gov.
- 15 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jan 2010 Actual patient number (369) added as reported by ClinicalTrials.gov.